The Global Antibacterial Market is estimated to be USD 31.3 Bn in 2023 and is expected to reach USD 48.41 Bn by 2028 growing at a CAGR of 9.11%.
However, increasing cases of ecological toxicity, antibacterial medication side effects, and the presence of multidrug-resistant (MDR) bacteria which are important current threats to public health, are restraining and creating challenges for the growth of the Global Antibacterial Market expansion.
2. Kyorin Pharmaceutical Receives Marketing Approval for Oral Quinolone Antibacterial Agent 'Lasvic Tablets 75mg'- 20th September 2019.
Market Dynamics
The global antibacterial market is being driven by factors such as increased cases of bacterial infections, changing climatical condition that causes bacterial infection, growing number aged population, and rising demand for efficient and affordable antibacterial Drugs. Furthermore, the key factor predicted to boost the growth of the global antibacterial market is the rising incidence of bacterial illnesses and sickness throughout the world, rising healthcare spending, and businesses concentrating on the clinical development of drugs to treat severe bacterial infections. In addition, an increase in the number of product approvals and subsequent product launches and the government initiative and support for the health care sector is expected to create future opportunities for the growth of the global antibacterial market.However, increasing cases of ecological toxicity, antibacterial medication side effects, and the presence of multidrug-resistant (MDR) bacteria which are important current threats to public health, are restraining and creating challenges for the growth of the Global Antibacterial Market expansion.
Market Segmentation
- The Global Antibacterial Market is segmented further based on Route of Administration, Drug Class, Distribution Channel, and Geography.
- By Route of Administration, the market is classified into enteral, parenteral. Amongst the two, the enteral segment is estimated to hold the highest market share during the forecast period.
- By Drug Class, the market is classified as B lactams, quinolones, macrolides, tetracycline, aminoglycoside, sulfonamide, phenicols, others. Amongst all the, B lactams segment is estimated to hold the highest market share during the forecast period.
- By Distribution Channel, the market is classified as hospital pharmacies, retail pharmacies, online pharmacies. Amongst all, the hospital pharmacies segment is estimated to hold the highest market share during the forecast period.
- By Geography, North America is projected to lead the market.
Recent Developments
1. Micurx Pharmaceuticals Inc. has won marketing approval from China's NMPA for its lead antibacterial, contezolid, for treating adults with complicated skin and soft tissue infection. - 2nd June 2021.2. Kyorin Pharmaceutical Receives Marketing Approval for Oral Quinolone Antibacterial Agent 'Lasvic Tablets 75mg'- 20th September 2019.
Company Profiles
Some of the companies covered in this report AbbVie Inc, Allecra Therapeutics GmbH, Basilea Pharmaceutica Ltd, Bayer AG, Boston Pharmaceuticals Inc. etc.Competitive Quadrant
The report includes Competitive Quadrant, a proprietary tool to analyze and evaluate the position of companies based on their Industry Position score and Market Performance score. The tool uses various factors for categorizing the players into four categories. Some of these factors considered for analysis are financial performance over the last 3 years, growth strategies, innovation score, new product launches, investments, growth in market share, etc.Why buy this report?
- The report offers a comprehensive evaluation of the Global Antibacterial Market. The report includes in-depth qualitative analysis, verifiable data from authentic sources, and projections about market size. The projections are calculated using proven research methodologies.
- The report has been compiled through extensive primary and secondary research. The primary research is done through interviews, surveys, and observation of renowned personnel in the industry.
- The report includes an in-depth market analysis using Porter’s 5 forces model and the Ansoff Matrix. In addition, the impact of Covid-19 on the market is also featured in the report.
- The report also includes the regulatory scenario in the industry, which will help you make a well-informed decision. The report discusses major regulatory bodies and major rules and regulations imposed on this sector across various geographies.
- The report also contains the competitive analysis using Positioning Quadrants, the Proprietary competitive positioning tool.
Report Highlights:
- A complete analysis of the market, including parent industry
- Important market dynamics and trends
- Market segmentation
- Historical, current, and projected size of the market based on value and volume
- Market shares and strategies of key players
- Recommendations to companies for strengthening their foothold in the market
Table of Contents
1 Report Description
2 Research Methodology
3 Executive Summary
4 Market Influencers
5 Market Analysis
6 Global Antibacterial Market, By Route of Administration
7 Global Antibacterial Market, By Drug Class
8 Global Antibacterial Market, By Distribution Channel
9 Global Antibacterial Market, By Geography
10 Competitive Landscape
11 Company Profiles
12 Appendix
Companies Mentioned
- AbbVie Inc
- Allecra Therapeutics GmbH
- Basilea Pharmaceutica Ltd
- Bayer AG
- Boston Pharmaceuticals Inc
- Bristol Myers Squibb Company
- Debiopharm Group
- Eli Lilly and Company
- GlaxoSmithKline PLC
- Iterum Therapeutics PLC
- Johnson & Johnson Service, Inc
- Kyorin Pharmaceutical Co., Ltd
- Melinta Therapeutics Merck & Co., Inc
- Micurx Pharmaceutical Inc
- NacuGen Therapeutics Inc
- Novartis International AG
- Pfizer, Inc
- R-Pharm Group
- Sanofi SA
- Shionogi Inc
- Sichuan Pharmaceutical Co., Ltd
- TenNor Therapeutics
- Theravance Biopharma, Inc
- VenatoRx Pharmaceuticals, Inc
- Wockhardt Ltd
Table Information
Report Attribute | Details |
---|---|
No. of Pages | 168 |
Published | February 2024 |
Forecast Period | 2023 - 2028 |
Estimated Market Value ( USD | $ 31.3 Billion |
Forecasted Market Value ( USD | $ 48.41 Billion |
Compound Annual Growth Rate | 9.1% |
Regions Covered | Global |
No. of Companies Mentioned | 25 |